A

Arcturus Therapeutics Holdings

D
ARCT
USD
0.38
(2.0663%)
Market Closed
20,996.00
Volume
-2.995
EPS
-
Div Yield
-6.977695
P/E
507,582,957.42
Market Cap
Today
2.4563%
1 Week
5.866%
1 Month
-21.399%
6 Months
-31.820%
12 Months
-4.137%
Year To Date
-40.280%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
E
EVO
0.42
(10.9375%)
USD
A
ACCO
0.02
(0.33%)
USD

Title:
Arcturus Therapeutics Holdings

Sector:
Healthcare
Industry:
Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Do you need help or have a question?
Contact Us